TAK-788-3001: TAK-788 as First-line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations
Nominating Site: Brampton Civic Hospital (William Osler Health System)
Promote your trial as an upcoming “Trial of the Month”!
Are you looking to boost recruitment for a trial at your institution? – Nominate today!
Increase awareness across our network by nominating a trial to be featured in an upcoming monthly newsletter, and here on our website. Simply email our Project Manager at firstname.lastname@example.org.